Hypertension mega-trials with cardiovascular end points: Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

This publication has 28 references indexed in Scilit:

• The Study on Cognition and Prognosis in the Elderly (SCOPE)
  Journal Of Hypertension, 2003
• The 24-hour blood pressure pattern: does it have implications for morbidity and mortality?
  The American Journal of Cardiology, 2002
• Comparative Effects of Ramipril on Ambulatory and Office Blood Pressures
  Hypertension, 2001
• Reduced Cardiovascular Morbidity and Mortality in Hypertensive Diabetic Patients on First-Line Therapy With an ACE Inhibitor Compared With a Diuretic/β-Blocker–Based Treatment Regimen
  Diabetes Care, 2001
• Tissue Angiotensin and Pathobiology of Vascular Disease
  Hypertension, 2001
• Characteristics of 15314 Hypertensive Patients at High Coronary Risk. The VALUE Trial
  Blood Pressure, 2001
• Major Cardiovascular Events in Hypertensive Patients Randomized to Doxazosin vs Chlorthalidone: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
  JAMA, 2000
• Hypertension Is Related to Cognitive Impairment
  Hypertension, 1998
• The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) Trial of Cardiovascular Events in Hypertension. Rationale and Design
  Blood Pressure, 1998
• Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context
  Published by Elsevier ,1990